<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3ASeries_B_funding</id>
	<title>Definition:Series B funding - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3ASeries_B_funding"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Series_B_funding&amp;action=history"/>
	<updated>2026-04-30T06:38:43Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Series_B_funding&amp;diff=17052&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Series_B_funding&amp;diff=17052&amp;oldid=prev"/>
		<updated>2026-03-15T10:09:03Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;🚀 &amp;#039;&amp;#039;&amp;#039;Series B funding&amp;#039;&amp;#039;&amp;#039; is a stage of [[Definition:Venture capital | venture capital]] financing in which an [[Definition:Insurtech | insurtech]] or insurance-focused company raises capital to scale operations after having demonstrated meaningful market traction — typically evidenced by growing [[Definition:Gross written premium (GWP) | premiums]], validated technology, and established partnerships with [[Definition:Insurance carrier | carriers]] or [[Definition:Reinsurance | reinsurers]]. Whereas [[Definition:Seed funding | seed]] and [[Definition:Series A funding | Series A]] rounds fund product development and early market entry, Series B capital is deployed to accelerate growth: expanding into new geographies or [[Definition:Line of business | lines of business]], deepening distribution relationships, hiring specialized [[Definition:Underwriting | underwriting]] or [[Definition:Actuarial science | actuarial]] talent, and investing in the technology infrastructure needed to handle larger policy volumes.&lt;br /&gt;
&lt;br /&gt;
⚙️ A typical Series B for an insurtech involves issuing [[Definition:Preferred stock | preferred equity]] to institutional investors — often growth-stage venture funds, corporate venture arms of incumbent insurers, or [[Definition:Private equity | private equity]] firms with an insurance thesis — at a [[Definition:Post-money valuation | post-money valuation]] that reflects the company&amp;#039;s demonstrated performance and forward trajectory. Round sizes vary widely, but in the insurtech space they often range from tens of millions to well over a hundred million dollars, depending on the capital intensity of the model. A [[Definition:Managing general agent (MGA) | MGA]] building a proprietary book under [[Definition:Binding authority agreement | binding authority]] may need less Series B capital than a full-stack carrier seeking its own [[Definition:Insurance license | licenses]] and [[Definition:Statutory capital | statutory capital]]. Investors at this stage scrutinize [[Definition:Loss ratio | loss ratio]] trends, unit economics, retention rates, and the strength of carrier or [[Definition:Reinsurance | reinsurance]] partnerships as indicators of whether the business can ultimately achieve profitability.&lt;br /&gt;
&lt;br /&gt;
📈 For the insurance industry at large, Series B rounds serve as a meaningful signal of which innovations are graduating from concept to viable enterprise. When a [[Definition:Cyber insurance | cyber]] MGA, a [[Definition:Parametric insurance | parametric]] platform, or a [[Definition:Claims management | claims]] automation firm reaches Series B, it indicates that sophisticated investors — many with deep insurance domain knowledge — have validated both the technology and the insurance economics behind the venture. This milestone often catalyzes deeper engagement from carrier partners willing to allocate more capacity and from [[Definition:Insurance broker | brokers]] ready to integrate the company&amp;#039;s products into their placement workflows. Series B also marks the stage at which governance expectations rise: boards become more formalized, [[Definition:Regulatory change | regulatory compliance]] frameworks are pressure-tested, and the groundwork is laid for later rounds — or eventually an exit through [[Definition:Initial public offering (IPO) | IPO]], acquisition, or strategic partnership.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Series A funding]]&lt;br /&gt;
* [[Definition:Venture capital]]&lt;br /&gt;
* [[Definition:Post-money valuation]]&lt;br /&gt;
* [[Definition:Insurtech]]&lt;br /&gt;
* [[Definition:Series C funding]]&lt;br /&gt;
* [[Definition:Seed funding]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>